These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24755913)

  • 21. Prophylactic etanercept treatment in cisplatin ototoxicity.
    Dasli S; Topdag M; Mutlu A; Kara A; Ozturk M
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3577-3583. PubMed ID: 28730299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
    Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of cisplatin-induced ototoxicity and prevention.
    Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
    Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.
    Lanvers-Kaminsky C; Ciarimboli G
    Pharmacogenomics; 2017 Dec; 18(18):1683-1695. PubMed ID: 29173064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
    Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
    Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers.
    Lee JW; Pussegoda K; Rassekh SR; Monzon JG; Liu G; Hwang S; Bhavsar AP; Pritchard S; Ross CJ; Amstutz U; Carleton BC;
    Ther Drug Monit; 2016 Aug; 38(4):423-31. PubMed ID: 26960170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
    Lynch ED; Gu R; Pierce C; Kil J
    Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.
    Vos HI; Guchelaar HJ; Gelderblom H; de Bont ES; Kremer LC; Naber AM; Hakobjan MH; van der Graaf WT; Coenen MJ; te Loo DM
    Pharmacogenet Genomics; 2016 May; 26(5):243-7. PubMed ID: 26928270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
    Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the protective effect of α-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study.
    Ozkul Y; Songu M; Basoglu MS; Ozturkcan S; Katilmis H
    J Craniofac Surg; 2014 Jul; 25(4):1515-8. PubMed ID: 24905944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
    Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
    Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
    Church MW; Blakley BW; Burgio DL; Gupta AK
    J Assoc Res Otolaryngol; 2004 Sep; 5(3):227-37. PubMed ID: 15185124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
    O'Leary SJ; Klis SF
    Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman.
    de Jong C; Sanders S; Creemers GJ; Burylo AM; Taks M; Schellens JHM; Deenen MJ
    Br J Clin Pharmacol; 2017 Sep; 83(9):2120-2122. PubMed ID: 28560854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.
    Jie H; Tao S; Liu L; Xia L; Charko A; Yu Z; Bance M; Yin S; Robertson GS; Wang J
    Gene Ther; 2015 Jul; 22(7):546-52. PubMed ID: 25809464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.
    Rainey RN; Ng SY; Llamas J; van der Horst GT; Segil N
    J Neurosci; 2016 Apr; 36(17):4758-70. PubMed ID: 27122034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in Otos is associated with cisplatin-induced ototoxicity.
    Spracklen TF; Whitehorn H; Vorster AA; Ramma L; Dalvie S; Ramesar RS
    Pharmacogenomics; 2014 Sep; 15(13):1667-76. PubMed ID: 25410892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
    Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
    Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.